Investor Contact: Press Contact: Steve Kunszabo Organovo Holdings, Inc. +1 (858) 224-1092 skunszabo@organovo.com Jessica Yingling Little Dog Communications +1 (858) 480-2411 jessica@litldog.com

ORGANOVO TO BEGIN TRADING ON NASDAQ STOCK MARKET

SAN DIEGO July 26, 2016 Organovo Holdings, Inc. (NYSE MKT:ONVO) ( Organovo ), a three-dimensional biology company focused on

delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced that it will move its stock exchange listing to the NASDAQ Stock Market from the NYSE MKT. The Company expects its common stock will begin trading

on the NASDAQ Global Market on August 8, 2016, and its shares will continue to trade under the ONVO ticker symbol. Organovo s common stock will continue to trade on the NYSE MKT until the market close on August 5, 2016.

NASDAQ is home to many of the world s most innovative biotechnology and healthcare companies and is a natural fit for Organovo, said

Keith Murphy, CEO, Organovo. We believe that this move will work to the long-term benefit of our shareholders.

About Organovo Holdings,

Organovo designs and creates functional, three-dimensional human tissues for use in medical research and therapeutic applications. The

Company develops 3D human tissue models through internal development and in collaboration with pharmaceutical, academic and other partners. Organovo s 3D human tissues have the potential to accelerate the drug discovery process, enabling

treatments to be developed faster and at lower cost. The Company s initial product is the exVive3DTM Human Liver Tissue for use in toxicology and other preclinical drug

testing. Additional products are in development, with the anticipated release of the exVive3D Human

Kidney Tissue scheduled for the third quarter of calendar year 2016. The Company also actively conducts early research on specific tissues for therapeutic use in direct surgical

applications. In addition to numerous scientific publications, the Company s technology has been featured in The Wall Street Journal, Time Magazine, The Economist, Forbes, and numerous other media outlets. Organovo is

changing the shape of life science research and transforming medical care. Learn more at www.organovo.com.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts constitute forward-looking statements as that term is defined

in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause the

Company s actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company s ability to develop, market and sell products and services based on its

technology; the expected benefits and efficacy of the Company s products, services and technology; the market acceptance of the Company s products and services; the Company s business, research, product development, regulatory

approval, marketing and distribution plans and strategies; the Company s ability to successfully complete the contracts and recognize revenue from its existing collaborative relationships; the Company s ability to secure additional

collaborative relationships; and the Company s ability to move its stock exchange listing to the NASDAQ Global Market from the NYSE MKT. These and other factors are identified and described in more detail in the Company s filings with

the SEC, including its Annual Report on Form 10-K filed with the SEC on June 9, 2016. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These

cautionary statements should be considered with any written or oral forward-looking statements that the Company may issue in the future. Except as required by applicable law, including the securities laws of the United States, the

Company does not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events.